Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Upgrade
Ceragon Networks upgraded to Buy from Hold at Needham » 07:34
05/04/21
05/04
07:34
05/04/21
07:34
CRNT

Ceragon Networks

/

+

Needham analyst Alex…

Needham analyst Alex Henderson upgraded Ceragon Networks to Buy from Hold with a $4.50 price target. The company's Q1 results were a "solid beat" with book-to-bill "substantially above" parity and the strongest orders in over two years, the analyst tells investors in a research note. Henderson adds that even in spite of the Covid surge in India, Ceragon orders in that region were strong, with the orders in North America also registering their strongest level in the company's history. The analyst further states that orders are "more important than the near-term supply constraints" as those are likely to improve as the year progresses.

ShowHide Related Items >><<
CRNT Ceragon Networks
/

+

CRNT Ceragon Networks
/

+

05/04/21 Needham
Ceragon Networks upgraded to Buy from Hold at Needham
03/12/21 Needham
Ceragon Networks upgraded to Hold from Underperform at Needham
03/12/21 Needham
Ceragon Networks upgraded to Hold from Underperform at Needham
02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform at Oppenheimer
CRNT Ceragon Networks
/

+

CRNT Ceragon Networks
/

+

Upgrade
Ceragon Networks upgraded to Buy from Hold at Needham » 06:10
05/04/21
05/04
06:10
05/04/21
06:10
CRNT

Ceragon Networks

/

+

Needham analyst Alex…

Needham analyst Alex Henderson upgraded Ceragon Networks to Buy from Hold with a $4.50 price target.

ShowHide Related Items >><<
CRNT Ceragon Networks
/

+

CRNT Ceragon Networks
/

+

03/12/21 Needham
Ceragon Networks upgraded to Hold from Underperform at Needham
03/12/21 Needham
Ceragon Networks upgraded to Hold from Underperform at Needham
02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform at Oppenheimer
02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform from Perform at Oppenheimer
CRNT Ceragon Networks
/

+

CRNT Ceragon Networks
/

+

On The Fly
Fly Intel: Pre-market Movers » 08:58
05/03/21
05/03
08:58
05/03/21
08:58
FOLD

Amicus

$9.83 /

-0.14 (-1.40%)

, BTX

Brooklyn ImmunoTherapeutics

$49.44 /

+15.96 (+47.67%)

, BRK.B

Berkshire Hathaway

$274.61 /

-3.12 (-1.12%)

, BRK.A

Berkshire Hathaway

$412,500.00 /

-4480 (-1.07%)

, EPD

Enterprise Products

$23.01 /

-0.42 (-1.79%)

, CRNT

Ceragon Networks

$3.40 /

-0.135 (-3.82%)

, AKTS

Akoustis

$11.22 /

-0.99 (-8.11%)

, LDI

LoanDepot

$19.87 /

+0.052 (+0.26%)

, ENBL

Enable Midstream

$7.41 /

-0.155 (-2.05%)

, EL

Estee Lauder

$314.00 /

-2.57 (-0.81%)

, PETS

PetMed Express

$29.39 /

-0.07 (-0.24%)

, CLX

Clorox

$182.29 /

-3.79 (-2.04%)

, VXRT

Vaxart

$10.79 /

+1.58 (+17.16%)

Check out this morning's…

ShowHide Related Items >><<
VXRT Vaxart
$10.79 /

+1.58 (+17.16%)

PETS PetMed Express
$29.39 /

-0.07 (-0.24%)

LDI LoanDepot
$19.87 /

+0.052 (+0.26%)

FOLD Amicus
$9.83 /

-0.14 (-1.40%)

EPD Enterprise Products
$23.01 /

-0.42 (-1.79%)

ENBL Enable Midstream
$7.41 /

-0.155 (-2.05%)

EL Estee Lauder
$314.00 /

-2.57 (-0.81%)

CRNT Ceragon Networks
$3.40 /

-0.135 (-3.82%)

CLX Clorox
$182.29 /

-3.79 (-2.04%)

BTX Brooklyn ImmunoTherapeutics
$49.44 /

+15.96 (+47.67%)

BRK.B Berkshire Hathaway
$274.61 /

-3.12 (-1.12%)

AKTS Akoustis
$11.22 /

-0.99 (-8.11%)

FOLD Amicus
$9.83 /

-0.14 (-1.40%)

04/28/21 Stifel
Protalix, Sanofi updates may signal headwinds for Avrobio, Amicus, says Stifel
04/14/21 Cantor Fitzgerald
Amicus upgraded to Overweight from Neutral at Cantor Fitzgerald
04/13/21 Cantor Fitzgerald
Amicus upgraded to Overweight from Neutral at Cantor Fitzgerald
03/01/21 Stifel
Amicus initiated with a Hold at Stifel
BTX Brooklyn ImmunoTherapeutics
$49.44 /

+15.96 (+47.67%)

BRK.B Berkshire Hathaway
$274.61 /

-3.12 (-1.12%)

07/07/20 Argus
Dominion price target lowered to $80 from $87 at Argus
BRK.A Berkshire Hathaway
$412,500.00 /

-4480 (-1.07%)

07/06/20 Guggenheim
Guggenheim 'loves' Dominion gas transmission sale, decision to scrap pipeline
EPD Enterprise Products
$23.01 /

-0.42 (-1.79%)

04/06/21 TD Securities
Enterprise Products initiated with a Buy at TD Securities
01/20/21 Mizuho
Enterprise Products price target raised to $27 from $24 at Mizuho
12/03/20 SMBC Nikko
Enterprise Products initiated with an Outperform at SMBC Nikko
11/23/20 Wolfe Research
Enterprise Products upgraded to Outperform from Peer Perform at Wolfe Research
CRNT Ceragon Networks
$3.40 /

-0.135 (-3.82%)

03/12/21 Needham
Ceragon Networks upgraded to Hold from Underperform at Needham
03/12/21 Needham
Ceragon Networks upgraded to Hold from Underperform at Needham
02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform at Oppenheimer
02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform from Perform at Oppenheimer
AKTS Akoustis
$11.22 /

-0.99 (-8.11%)

03/30/21 Roth Capital
Akoustis secures WiFi 6e reference design win, says Roth Capital
02/23/21 Roth Capital
Akoustis equity financing improves balance sheet, says Roth Capital
02/02/21 Lake Street
Akoustis price target raised to $19 from $10 at Lake Street
02/01/21 Roth Capital
Akoustis price target raised to $25 from $16 at Roth Capital
LDI LoanDepot
$19.87 /

+0.052 (+0.26%)

04/21/21 Barclays
LoanDepot downgraded to Equal Weight from Overweight at Barclays
04/05/21 Cowen
Risk to mortgage servicers rises as CFPB proposes foreclosure policy, says Cowen
03/26/21 Credit Suisse
Credit Suisse lowers estimates on mortgage originators
03/09/21 William Blair
LoanDepot initiated with an Outperform at William Blair
ENBL Enable Midstream
$7.41 /

-0.155 (-2.05%)

03/02/21 Barclays
Enable Midstream upgraded to Equal Weight from Underweight at Barclays
03/01/21 Mizuho
Enable Midstream downgraded to Neutral from Buy at Mizuho
11/16/20 Mizuho
OGE Energy downgraded to Neutral on valuation at Mizuho
10/26/20 Mizuho
CenterPoint Energy price target raised to $25 from $20 at Mizuho
EL Estee Lauder
$314.00 /

-2.57 (-0.81%)

04/27/21 Stifel
Estee Lauder price target raised to $335 from $290 at Stifel
04/27/21 Deutsche Bank
Estee Lauder price target raised to $337 from $316 at Deutsche Bank
04/22/21 Evercore ISI
Estee Lauder price target raised to $355 from $300 at Evercore ISI
04/16/21 JPMorgan
Estee Lauder price target raised to $336 from $299 at JPMorgan
PETS PetMed Express
$29.39 /

-0.07 (-0.24%)

03/05/21 Sidoti
PetMed Express upgraded to Buy from Neutral at Sidoti
01/27/21 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
08/19/20 Sidoti
PetMed Express upgraded to Buy from Neutral at Sidoti
CLX Clorox
$182.29 /

-3.79 (-2.04%)

05/03/21 Credit Suisse
Clorox price target lowered to $185 from $205 at Credit Suisse
05/03/21 Wells Fargo
Clorox downgraded to Underweight from Overweight at Wells Fargo
05/03/21 Deutsche Bank
Clorox price target lowered to $186 from $195 at Deutsche Bank
04/16/21 JPMorgan
Clorox price target lowered to $196 from $205 at JPMorgan
VXRT Vaxart
$10.79 /

+1.58 (+17.16%)

03/04/21 B. Riley
Vaxart price target lowered to $13 from $16 at B. Riley Securities
11/18/20 B. Riley
Vaxart price target lowered to $16 from $22 at B. Riley Securities
10/13/20 B. Riley
B. Riley views Vaxart as key player in 'second wave' of Covid vaccines
09/09/20 B. Riley
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
VXRT Vaxart
$10.79 /

+1.58 (+17.16%)

PETS PetMed Express
$29.39 /

-0.07 (-0.24%)

LDI LoanDepot
$19.87 /

+0.052 (+0.26%)

FOLD Amicus
$9.83 /

-0.14 (-1.40%)

EPD Enterprise Products
$23.01 /

-0.42 (-1.79%)

ENBL Enable Midstream
$7.41 /

-0.155 (-2.05%)

EL Estee Lauder
$314.00 /

-2.57 (-0.81%)

CRNT Ceragon Networks
$3.40 /

-0.135 (-3.82%)

CLX Clorox
$182.29 /

-3.79 (-2.04%)

BRK.B Berkshire Hathaway
$274.61 /

-3.12 (-1.12%)

BRK.A Berkshire Hathaway
$412,500.00 /

-4480 (-1.07%)

AKTS Akoustis
$11.22 /

-0.99 (-8.11%)

  • 11
    Feb
FOLD Amicus
$9.83 /

-0.14 (-1.40%)

EL Estee Lauder
$314.00 /

-2.57 (-0.81%)

CLX Clorox
$182.29 /

-3.79 (-2.04%)

BRK.B Berkshire Hathaway
$274.61 /

-3.12 (-1.12%)

BRK.A Berkshire Hathaway
$412,500.00 /

-4480 (-1.07%)

VXRT Vaxart
$10.79 /

+1.58 (+17.16%)

LDI LoanDepot
$19.87 /

+0.052 (+0.26%)

FOLD Amicus
$9.83 /

-0.14 (-1.40%)

EPD Enterprise Products
$23.01 /

-0.42 (-1.79%)

EL Estee Lauder
$314.00 /

-2.57 (-0.81%)

CRNT Ceragon Networks
$3.40 /

-0.135 (-3.82%)

CLX Clorox
$182.29 /

-3.79 (-2.04%)

BRK.B Berkshire Hathaway
$274.61 /

-3.12 (-1.12%)

BRK.A Berkshire Hathaway
$412,500.00 /

-4480 (-1.07%)

AKTS Akoustis
$11.22 /

-0.99 (-8.11%)

VXRT Vaxart
$10.79 /

+1.58 (+17.16%)

FOLD Amicus
$9.83 /

-0.14 (-1.40%)

EPD Enterprise Products
$23.01 /

-0.42 (-1.79%)

EL Estee Lauder
$314.00 /

-2.57 (-0.81%)

CLX Clorox
$182.29 /

-3.79 (-2.04%)

AKTS Akoustis
$11.22 /

-0.99 (-8.11%)

Earnings
Ceragon Networks reaffirms FY21 revenue view $275M-$295M, consensus $283.29M » 07:06
05/03/21
05/03
07:06
05/03/21
07:06
CRNT

Ceragon Networks

$3.40 /

-0.135 (-3.82%)

The company said,…

The company said, "We continue to target revenue growth in 2021. Although we still expect a slow start for the first half of the year, we continue to expect yearly revenue to be between $275M-$295M. Now all that said, the growing component shortage may have a negative impact on the timeliness of our Q2 and rest-of-the-year deliveries and may lead to a probable push of revenues between quarters until the shortage is resolved."

ShowHide Related Items >><<
CRNT Ceragon Networks
$3.40 /

-0.135 (-3.82%)

CRNT Ceragon Networks
$3.40 /

-0.135 (-3.82%)

03/12/21 Needham
Ceragon Networks upgraded to Hold from Underperform at Needham
03/12/21 Needham
Ceragon Networks upgraded to Hold from Underperform at Needham
02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform at Oppenheimer
02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform from Perform at Oppenheimer
CRNT Ceragon Networks
$3.40 /

-0.135 (-3.82%)

CRNT Ceragon Networks
$3.40 /

-0.135 (-3.82%)

Earnings
Ceragon Networks reports Q1 non-GAAP EPS (1c), consensus (3c) » 07:05
05/03/21
05/03
07:05
05/03/21
07:05
CRNT

Ceragon Networks

$3.40 /

-0.135 (-3.82%)

Reports Q1 revenue…

Reports Q1 revenue $68.3M, consensus $64.55M. Ira Palti, President & CEO, commented: "2021 has been off to a good start both for the telecom industry in general and for us at Ceragon specifically. The amount of data flowing around the globe has increased at an exponential rate. As Tier-1 and Tier-2 operators step up their efforts to provide enhanced 4G coverage as well as new 5G services, many of them turn to Ceragon. In Q1 the accelerated 5G evolution along with the growing OpenRan movement has kept Ceragon's growing suite of innovative solutions in the spotlight. We achieved three new 5G design wins, saw very strong bookings across different regions, and were selected to participate in an OpenRan trial in TIM Brazil. Even though the industry is currently facing component shortages, which might affect our short-term deliveries, the global telecom industry is fast moving into a new era and Ceragon is well prepared to excel in it."

ShowHide Related Items >><<
CRNT Ceragon Networks
$3.40 /

-0.135 (-3.82%)

CRNT Ceragon Networks
$3.40 /

-0.135 (-3.82%)

03/12/21 Needham
Ceragon Networks upgraded to Hold from Underperform at Needham
03/12/21 Needham
Ceragon Networks upgraded to Hold from Underperform at Needham
02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform at Oppenheimer
02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform from Perform at Oppenheimer
CRNT Ceragon Networks
$3.40 /

-0.135 (-3.82%)

CRNT Ceragon Networks
$3.40 /

-0.135 (-3.82%)

Over a month ago
Hot Stocks
Doron Arazi to succeed Ira Palti as CEO of Ceragon Networks » 07:01
04/12/21
04/12
07:01
04/12/21
07:01
CRNT

Ceragon Networks

$3.77 /

-0.1 (-2.59%)

Ceragon Networks…

Ceragon Networks announced that its Board of Directors has appointed Doron Arazi, the company's former deputy CEO & CFO, as its CEO from beginning of July. Doron Arazi will be succeeding CEO Ira Palti, effective on the same date. Ira Palti will remain on the Board of Directors of Ceragon and will be appointed as Vice Chairman.

ShowHide Related Items >><<
CRNT Ceragon Networks
$3.77 /

-0.1 (-2.59%)

CRNT Ceragon Networks
$3.77 /

-0.1 (-2.59%)

03/12/21 Needham
Ceragon Networks upgraded to Hold from Underperform at Needham
03/12/21 Needham
Ceragon Networks upgraded to Hold from Underperform at Needham
02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform at Oppenheimer
02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform from Perform at Oppenheimer
CRNT Ceragon Networks
$3.77 /

-0.1 (-2.59%)

CRNT Ceragon Networks
$3.77 /

-0.1 (-2.59%)

Hot Stocks
Ceragon Networks selected by TIM Brazil to test 5G OpenRAN providers » 05:04
04/05/21
04/05
05:04
04/05/21
05:04
CRNT

Ceragon Networks

$3.83 /

+0.045 (+1.19%)

Ceragon Networks…

Ceragon Networks announced that it has been selected by TIM Brazil to participate in the joint work they are carrying out together with Telecom Infra-Project, or TIP, and the National Telecommunication Institute, or INATEL, to test providers for 5G OpenRAN. The open field trial will take place on the INATEL campus, in Santa Rita do Sapucai and will incorporate software and hardware vendors, operators, university members and members of the TIP working groups. The trials will be led by TIP, who has been promoting open and disaggregated solutions for telecom networks. The trials aim to test and validate different combinations of OpenRAN components from various suppliers and their performance under conditions similar to that of a commercial network

ShowHide Related Items >><<
CRNT Ceragon Networks
$3.83 /

+0.045 (+1.19%)

CRNT Ceragon Networks
$3.83 /

+0.045 (+1.19%)

03/12/21 Needham
Ceragon Networks upgraded to Hold from Underperform at Needham
03/12/21 Needham
Ceragon Networks upgraded to Hold from Underperform at Needham
02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform at Oppenheimer
02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform from Perform at Oppenheimer
CRNT Ceragon Networks
$3.83 /

+0.045 (+1.19%)

CRNT Ceragon Networks
$3.83 /

+0.045 (+1.19%)

Hot Stocks
Ceragon Networks announces frame agreement valued at up to $23M » 07:02
03/17/21
03/17
07:02
03/17/21
07:02
CRNT

Ceragon Networks

$4.32 /

-0.09 (-2.04%)

Ceragon Networks…

Ceragon Networks announced that a Tier 1 Operator in the Pacific Rim has placed a significant follow-on frame agreement with Ceragon for its flexible wireless hauling solutions, in order to transform its network towards 5G. To create a better, more connected nation, Ceragon will help the operator in expanding its urban network coverage, reliability, and speeds, as well as extend its network to rural countryside to achieve nationwide coverage. This frame agreement is valued at up to $23M throughout 2021 and 2022.

ShowHide Related Items >><<
CRNT Ceragon Networks
$4.32 /

-0.09 (-2.04%)

CRNT Ceragon Networks
$4.32 /

-0.09 (-2.04%)

03/12/21 Needham
Ceragon Networks upgraded to Hold from Underperform at Needham
03/12/21 Needham
Ceragon Networks upgraded to Hold from Underperform at Needham
02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform at Oppenheimer
02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform from Perform at Oppenheimer
CRNT Ceragon Networks
$4.32 /

-0.09 (-2.04%)

CRNT Ceragon Networks
$4.32 /

-0.09 (-2.04%)

Upgrade
Ceragon Networks upgraded to Hold from Underperform at Needham » 06:34
03/12/21
03/12
06:34
03/12/21
06:34
CRNT

Ceragon Networks

$4.16 /

+0.23 (+5.85%)

Needham analyst Alex…

Needham analyst Alex Henderson upgraded Ceragon Networks to Hold from Underperform. The analyst notes that his prior downgrade was due to the stock getting caught up in the "retail/Reddit frenzy", but this has now been "corrected" and shares returned to a "reasonable" range. As 5G moves closer, Ceragon Networks is also positioned to benefit, the analyst tells investors in a research note, even though this is a "slow and long process" in terms of adoption outside the U.S.

ShowHide Related Items >><<
CRNT Ceragon Networks
$4.16 /

+0.23 (+5.85%)

CRNT Ceragon Networks
$4.16 /

+0.23 (+5.85%)

03/12/21 Needham
Ceragon Networks upgraded to Hold from Underperform at Needham
02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform at Oppenheimer
02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform from Perform at Oppenheimer
01/20/21
Fly Intel: Top five analyst downgrades
CRNT Ceragon Networks
$4.16 /

+0.23 (+5.85%)

CRNT Ceragon Networks
$4.16 /

+0.23 (+5.85%)

Upgrade
Ceragon Networks upgraded to Hold from Underperform at Needham » 06:20
03/12/21
03/12
06:20
03/12/21
06:20
CRNT

Ceragon Networks

$4.16 /

+0.23 (+5.85%)

Needham analyst Alex…

Needham analyst Alex Henderson upgraded Ceragon Networks to Hold from Underperform.

ShowHide Related Items >><<
CRNT Ceragon Networks
$4.16 /

+0.23 (+5.85%)

CRNT Ceragon Networks
$4.16 /

+0.23 (+5.85%)

02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform at Oppenheimer
02/22/21 Oppenheimer
Ceragon Networks upgraded to Outperform from Perform at Oppenheimer
01/20/21
Fly Intel: Top five analyst downgrades
01/20/21 Needham
Ceragon Networks double-downgraded to Underperform from Buy at Needham
CRNT Ceragon Networks
$4.16 /

+0.23 (+5.85%)

CRNT Ceragon Networks
$4.16 /

+0.23 (+5.85%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.